MedTrace Logo

Evaluation of the "ActiveWaiting App" Encouraging Active Exercise-related Use of Waiting Time

NCT06321926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-06-25

No results posted yet for this study

Summary

The goal of this study (waitlist control study) is to evaluate the effectiveness of the ActiveWaiting App on increasing physical activity and improving quality of life in physically inactive adults in Austria.

The main questions it aims to answer are:

1. Does the provision of the ActiveWaiting App lead to increased physical activity behaviour, compared to a no-intervention control group?
2. Does the provision of the ActiveWaiting App lead to increased health-related quality of life, compared to a no-intervention control group? Participants will use the ActiveWaiting App over a period of seven days. During this period, they will answer daily questionnaires (3 - 6 questions) in order to gather their actual physical activity behaviour. Before and after the intervention period additional questionnaires on health-related quality of life will be sent to the participants.

Participants in the waitlist control group will have a control period (seven days) before using the app.

Researchers will compare the intervention group with the waitlist control group to see if the ActiveWating App has an effect

* on physical activity behaviour and
* on quality of life.

Conditions

  • Physical Inactivity

Interventions

DEVICE

ActiveWaiting App

The final prototype aims at increasing physical activity during the day by providing exercises for waiting periods and other idle time periods. The user can choose from a pool of exercises from five different categories (11 exercises for endurance, 65 exercises for strength, 67 exercises for flexibility, 11 exercises for relaxation, or 5 exercises for balance). Additionally, within each category, the user can choose only "discrete" exercises which are not noticeable to an observer. If the user has used the app before, the last or previously saved settings can be chosen. Every input field has an information icon showing a short description of the input field.

Sponsors & Collaborators

  • Ludwig Boltzmann Institute for Digital Health and Prevention

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-06-24
Completion
2024-06-24

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06321926 on ClinicalTrials.gov